I'm glad they announced it officially...
I liked this statement:
“As joint pain and loss of limb strength are common aspects of CHIKV induced disease,
these critical findings provide confidence in PPS as a potential world first CHIKV therapy”
--Dr Lara Herrero
Ann: CHIKV study data published in Peer-Reviewed Journal, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $180.8M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 46.0¢ | 44.0¢ | $54.12K | 119.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 46806 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 364 | 1 |
View Market Depth
| Last trade - 10.12am 04/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |